These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25976907)

  • 61. A prospective comparison of echocardiography and device algorithms for atrioventricular and interventricular interval optimization in cardiac resynchronization therapy.
    Kamdar R; Frain E; Warburton F; Richmond L; Mullan V; Berriman T; Thomas G; Tenkorang J; Dhinoja M; Earley M; Sporton S; Schilling R
    Europace; 2010 Jan; 12(1):84-91. PubMed ID: 19892713
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients.
    Jędrzejczyk-Patej E; Lenarczyk R; Mazurek M; Liberska A; Przybylska-Siedlecka K; Podolecki T; Kowalczyk J; Sokal A; Leopold-Jadczyk A; Kowalski O; Kalarus Z
    Europace; 2016 Mar; 18(3):436-44. PubMed ID: 26017467
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial.
    Birnie D; Lemke B; Aonuma K; Krum H; Lee KL; Gasparini M; Starling RC; Milasinovic G; Gorcsan J; Houmsse M; Abeyratne A; Sambelashvili A; Martin DO
    Heart Rhythm; 2013 Sep; 10(9):1368-74. PubMed ID: 23851059
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comprehensive cardiac resynchronization therapy optimization in the real world.
    Steffel J; Rempel H; Breitenstein A; Schmidt S; Namdar M; Krasniqi N; Holzmeister J; Lüscher TF; Ruschitzka F; Hürlimann D
    Cardiol J; 2014; 21(3):316-24. PubMed ID: 23990194
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.
    Zanon F; Baracca E; Pastore G; Fraccaro C; Roncon L; Aggio S; Noventa F; Mazza A; Prinzen F
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):377-83. PubMed ID: 24668162
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Time-dependent effect of cardiac resynchronization therapy on ventricular repolarization and ventricular arrhythmias.
    Itoh M; Yoshida A; Fukuzawa K; Kiuchi K; Imamura K; Fujiwara R; Suzuki A; Nakanishi T; Yamashita S; Matsumoto A; Hirata K
    Europace; 2013 Dec; 15(12):1798-804. PubMed ID: 23736809
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Noninvasive, automatic optimization strategy in cardiac resynchronization therapy.
    Reumann M; Osswald B; Doessel O
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():209-12. PubMed ID: 17584727
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interventricular delay interval optimization in cardiac resynchronization therapy guided by echocardiography versus guided by electrocardiographic QRS interval width.
    Bertini M; Ziacchi M; Biffi M; Martignani C; Saporito D; Valzania C; Diemberger I; Cervi E; Frisoni J; Sangiorgi D; Branzi A; Boriani G
    Am J Cardiol; 2008 Nov; 102(10):1373-7. PubMed ID: 18993158
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel measure of electrical dyssynchrony predicts response in cardiac resynchronization therapy: Results from the SMART-AV Trial.
    Tereshchenko LG; Cheng A; Park J; Wold N; Meyer TE; Gold MR; Mittal S; Singh J; Stein KM; Ellenbogen KA;
    Heart Rhythm; 2015 Dec; 12(12):2402-10. PubMed ID: 26272523
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: Efficacy, safety, and impact on mortality.
    Landolina M; Lunati M; Boriani G; Pietro Ricci R; Proclemer A; Facchin D; Rordorf R; Morani G; Maines M; Gasparini G; Molon G; Turrini P; Gasparini M;
    Heart Rhythm; 2016 Feb; 13(2):472-80. PubMed ID: 26477710
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Should we optimize cardiac resynchronization therapy during exercise?
    Bogaard MD; Kirkels JH; Hauer RN; Loh P; Doevendans PA; Meine M
    J Cardiovasc Electrophysiol; 2010 Nov; 21(11):1307-16. PubMed ID: 20550613
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: a post hoc analysis of the Clinical Evaluation on Advanced Resynchronization (CLEAR) pilot study.
    Delnoy PP; Ritter P; Naegele H; Orazi S; Szwed H; Zupan I; Goscinska-Bis K; Anselme F; Martino M; Padeletti L
    Europace; 2013 Aug; 15(8):1174-81. PubMed ID: 23493410
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of atrioventricular and interventricular delays on gas exchange during exercise in patients with heart failure.
    Kim CH; Cha YM; Shen WK; Maccarter DJ; Taylor BJ; Johnson BD
    J Heart Lung Transplant; 2014 Apr; 33(4):397-403. PubMed ID: 24594137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.